BMP Delivery Strategies for Bone Defects
Combinations of natural or synthetic scaffold delivery platforms, bone grafting materials, and bioactive molecules such as bone morphogenetic protein 2 (BMP-2) form the current paradigm in advanced bone regeneration technologies. However, the use of BMPs, especially in higher doses, has been associated with reports of heterotopic bone formation, increased inflammation, osteolysis, and possible increased cancer risk.